Trials / Conditions / Bacteremia Due to Staphylococcus Aureus
Bacteremia Due to Staphylococcus Aureus
4 registered clinical trials studyying Bacteremia Due to Staphylococcus Aureus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia NCT07384702 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 2 |
| Withdrawn | ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis NCT05329168 | Lysovant | Phase 2 |
| Completed | Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacterem NCT05184764 | Armata Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Terminated | Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremi NCT01975662 | Singapore General Hospital | Phase 2 |